decreased body size_Tg(Ckmm-Cav3)1Ysu/0

http://metadb.riken.jp/0001265IC57BLSlcDBASlcTgCkmmCav31Ysu0TgCkmmCav31Ysu

decreased body size_Tg(Ckmm-Cav3)1Ysu/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Yoshihide Sunada
  http://metadb.riken.jp/db/mgi_rdf/MGI:3621120

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Ckmm-Cav3)1Ysu/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Ckmm-Cav3)1Ysu

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/Slc * DBA/Slc

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased body size
  http://purl.obolibrary.org/obo/MP_0001265

文献

http://purl.org/net/cito/citesAsAuthority

• Yutaka. Ohsawa, et.al., Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity., Human molecular genetics, 2004, 13
  http://rdf.ncbi.nlm.nih.gov/pubmed/14645200
• Y. Sunada, et.al., Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity., Human molecular genetics, 2001, 10
  http://rdf.ncbi.nlm.nih.gov/pubmed/11159934